Oslo, Norway (29 March 2021 ) - Reference is made to the offer document dated8 March 2021 (the "Offer Document") for the recommended voluntary offer by Compagnie des Levures Lesaffre (the "Offeror") to acquire all outstanding shares inNattoPharma ASA ("NattoPharma " or the "Company") against a consideration in cash ofNOK 35 per share (the "Offer"), and further reference is made to the stock exchange announcement dated29 March 2021 in which the Offeror announced that the voluntary offer is completed.Synergia Life Sciences Pvt. Ltd sold 1,360,000 shares in this tranasaction. Following this transactionSynergia Life Sciences Pvt. Ltd. will not hold any shares inNattoPharma . *** For more information, please contact:Robert Schrama , CFO E-mail: robert.schrama@nattopharma.com This information is subject to the disclosure requirements pursuant to section 5 -12 of theNorwegian Securities
Click here for more information
© Oslo Bors ASA, source